ArticleKidney international reports2026

Response to the Letter to the Editor Entitled "Critical Reappraisal of Obinutuzumab Randomized Trials in Membranous Nephropathy".

Kajaree Giri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.